Define "effective": The curious case of chronic cancer

Hastings Center Report

Volumn 39, Issue 6, 2009, Pages 17-20

  Berlinger, Nancy ^a   Flamm, Anne Lederman ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER PALLIATIVE THERAPY; CHRONIC DISEASE; CHRONICITY; COMPARATIVE EFFECTIVENESS; COMPARATIVE STUDY; DOCTOR PATIENT RELATION; EVIDENCE BASED MEDICINE; HEALTH CARE QUALITY; HUMAN; LONG TERM CARE; MEDICAL DECISION MAKING; MEDICAL RESEARCH; METASTASIS; NEOPLASM; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL; SHORT SURVEY;

EID: 70649115603     PISSN: 00930334     EISSN: 1552146X     Source Type: Journal    
DOI: 10.1353/hcr.0.0203     Document Type: Short Survey

References (9)

1. Nancy Berlinger and Anne Lederman Flamm, "Define 'Effective': The Curious Case of Chronic Cancer" Hastings Center Report 39, no. 6(2009):17-20.
2. A. D. Seidman, "Sequential Single-Agent Chemotherapy for Metastatic Breast Cancer: Therapeutic Nihilism or Realism?" Journal of Clinical Oncology 21(2003):577-79, at 578.
3. G. W. Sledge et al., "Phase III Trial of Doxorubicin, Paclitaxel, and the Combination of Doxorubicin and Paclitaxel as Front-Line Chemotherapy for Metastatic Breast Cancer: An Intergroup Trial (E11193)," Journal of Clinical Oncology 21(2003):588-92.
4. Seidman, "Sequential Single-Agent Chemotherapy for Metastatic Breast Cancer. "
5. C. G. Murphy and A. D. Seidman, "Evolving Approaches to Metastatic Breast Cancer Previously Treated with Anthracyclines and Taxanes," Clinical Breast Cancer 9, suppl. 2 (2009) : S58-65.
6. T. Fojo and C. Grady, "How Much Is Life Worth: Cetuximab, Non-Small Cell Lung Cancer, and the $440 Billion Question," Journal of the National Cancer Institute 101, no. 15(2009):11-5.
7. E. C. Schneider et al., "Developing a System to Assess the Quality of Cancer Care: ASCO's National Initiative on Cancer Care Quality," Journal of Clinical Oncology 22(2004):2985-91.
8. S. E. Harrington and T. J. Smith, "The Role of Chemotherapy at the End of Life: When Is Enough, Enough?" Journal of the American Medical Association 299(2008):2667-78.
9. B. E. Hillner and T. J. Smith, "Efficacy Does Not Necessarily Translate to Cost Effectiveness: A Case Study in the Challenges Associated with 21st Century Cancer Drug Pricing," Journal of Clinical Oncology 27(2009):2111-13.